Noninvasive monitoring of intracranial pressure: a new approach for neonatal clinical pharmacology.
Measurements taken with the pressure-activated fiberoptic sensor should provide better insight into the relative usefulness of various agents such as glycerol and corticosteroids in the reduction of intracranial pressure. It is also useful in monitoring pressure changes during asphyxia-hypoxia, convulsions, and anesthesia, and in demonstrating the effects of drugs such as furosemide on intracranial pressure.
D000818:Animals; D001929:Brain Edema / Q000188:drug therapy; D006801:Humans; D006849:Hydrocephalus / Q000188:drug therapy; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007427:Intracranial Pressure / Q000187:drug effects; D008991:Monitoring, Physiologic / Q000295:instrumentation / Q000379:methods*